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LETTERS
Emergence of 
New Delhi Metallo-
β-Lactamase, 
Austria
To the Editor: Extended-spec-
trum  β-lactamase–producing  Enter-
obacteriaceae strains have emerged as 
a major public health problem through-
out the world, particularly in India 
and Pakistan. The widespread use of 
carbapenems, the only agents reliably 
active against these bacteria, resulted 
in the emergence of a new resistance 
mechanism. New Delhi metallo-β-
lactamase (NDM-1) was ﬁ  rst detected 
in a Klebsiella pneumoniae isolate in 
2008 from a Swedish patient of Indian 
origin; it has since been reported in 
increasing numbers of infections in 
patients from India, Pakistan, and the 
United Kingdom (1–3).
NDM-1 shares very little iden-
tity with other metallo-β-lactamase 
enzymes; Enterobacteriaceae isolates 
with NDM-1 show high resistance to 
nearly all commonly used antibacte-
rial agents (4). Most NDM-1 patients 
in Europe and the United States had 
received medical care in India or 
Pakistan before isolation of the strain. 
However, the emergence of NDM-1 
poses the risk of plasmid-mediated 
transfer of the carbapenemase enzyme 
blaNDM-1  between different bacterial 
strains, which could lead to serious 
public health issues (3,5). We report 
the emergence of NDM-1–positive K. 
pneumoniae in Austria in 2009–2010.
Primers for PCR detection of 
NDM-1 were designed according to 
GenBank (National Center for Biotech-
nology Information, National Institutes 
of Health, Bethesda, MD, USA) data-
base entry AB571289.1 (www.ncbi.
nlm.nih.gov/nuccore/300422615). 
The forward primer NDM-1gf 5′-ACC 
GCC TGG ACC GAT GAC CA-3′ 
(positions 80–99), and reverse primer 
NDM-1gr 5′-GCC AAA GTT GGG 
CGC GGT TG-3′ (positions 343–324) 
were used.
PCR conditions were the follow-
ing: initial denaturation at 94°C for 5 
min; 35 cycles at 95°C for 30 s, 58°C 
for 30 s, and 72°C for 30 s; and ﬁ  nal 
incubation for 10 min at 72°C. Taq 
DNA polymerase and dNTPs from 
QIAGEN (Hilden, Germany) were 
used. The 264-bp fragment was se-
quenced and compared with the Gen-
Bank entry for NDM-1.
Carbapenemase-producing  K. 
pneumoniae has been detected in 26 
isolates obtained during September 
2007 through August 2010 from 6 
patients at the University Hospital, 
Graz, Austria. Eight isolates from 2 
patients were found to carry the plas-
mid NDM-1. The ﬁ  rst case involving 
NDM-1 occurred in November 2009, 
and the second occurred in August 
2010. Automated repetitive element 
PCR, conducted with the DiversiLab 
system (bioMérieux, Marcy l’Etoile, 
France) (6) showed a genetic related-
ness of isolates from the 2 patients of 
≤81.1% (5 band differences), which 
indicated independent clones. Isolated 
NDM-1 strains exhibited resistance to 
nearly all antibacterial agents, includ-
ing aztreonam, ciproﬂ  oxacin, and gen-
tamicin, and were susceptible to only 
colistin, tigecycline, and amikacin 
(Table).
Patient 1, a 30-year-old Austrian 
man, was admitted to University Hos-
pital (Graz, Austria) in November 
2009. His medical history showed he 
had experienced multiple open frac-
tures of his upper and lower left leg 
as well as rectal laceration because of 
a motorcycle accident in Pakistan. His 
treatment had taken place primarily in 
surgery departments in Pakistan and 
India. During his hospitalization in 
Austria, multiple resistant gram-nega-
tive bacteria were isolated, including 
highly resistant NDM-1–producing 
K. pneumoniae. The NDM-1 strain 
was isolated twice, from a sacral de-
cubitus ulcer and from stool. After 5 
months of recurrent hospitalizations 
with various infectious complications, 
multiple anti-infective regimens, and 
surgical interventions required to treat 
fractures resulting from the patient’s 
motorcycle accident, the patient was 
released without further medical prob-
lems.
In August 2010, patient 2, a 14-
year-old boy from Kosovo, was trans-
ferred from a hospital in that country 
to the Department of Pediatrics, Uni-
versity Hospital (Graz, Austria) with 
multiple intra-abdominal abscesses 
and peritonitis. He had undergone an 
appendectomy in Pristina, Kosovo, 
in April 2010, after which abdominal 
sepsis developed. His travel history 
was completely unremarkable. On 
the day of admission, multiple-drug 
resistant K. pneumoniae was isolated 
from 5 sites (2 swab samples from the 
abdominal wound, 1 sample from the 
throat, 1 sample of secretion from an 
abdominal ﬁ  stula, and 1 sample from 
stool). As of November 2010, the pa-
tient still required medical care and 
remained hospitalized.
Most plasmids with the carbap-
enemase enzyme blaNDM-1 were shown 
to be readily transferable and prone 
to rearrangement, which indicates 
a potential to spread among bacte-
rial populations (3). So far, NDM-1 
carbapenemase has been detected 
in  K. pneumoniae,  Escherichia coli, 
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Table. Antimicrobial drug susceptibilities of New Delhi metallo-E-lactamase strains 
isolated from 2 patients, Graz, Austria, 2010* 
Drug 
MIC, mg/L 
Patient 1 isolate  Patient 2 isolate 
Colistin 0.125  0.125 
Tigecycline 2 0.125 
Amikacin 8 2
*Only substances for which isolates had susceptibility are listed. MICs were determined by the Etest 
method (AB BIODISK, Solna, Sweden). Susceptibility was determined according to relevant testing 
conditions and the new susceptibility interpretation standards proposed by the Clinical and 
Laboratory Standards Institute (www.clsi.org). LETTERS
Citrobacter freundii,  Enterobacter 
cloacae, and Morganella morganii 
and has shown resistance to nearly 
all classes of antibacterial agents, ex-
cept polymyxins and tigecycline (2,3). 
Kumarasamy et al. recently reported 
the identiﬁ  cation of 37 isolates with 
NDM-1 in the United Kingdom. The 
isolates came from 29 patients, of 
whom at least 17 had traveled to India 
or Pakistan in the year preceding iden-
tiﬁ  cation of NDM-1; 14 patients had 
been admitted to a hospital in those 
countries (2). 
NDM-1 has also been isolated 
from 3 patients in the United States, 
all of whom had recently received 
medical care in India (7). In contrast, 1 
of the 2 patients with K. pneumoniae–
carrying NDM-1 reported here was 
transferred to our hospital from Ko-
sovo in southeastern Europe and had 
an unremarkable travel history. Im-
mediate action is needed to control the 
spread of NDM-1 and avoid a world-
wide public health problem.
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Carbapenemases 
in Enterobacteria, 
Hong Kong, 
China, 2009
To the Editor: Carbapenems are 
often the recommended treatment for 
serious infections caused by extend-
ed-spectrum  β-lactamase–producing 
enterobacteria. However, enzyme-
mediated carbapenem resistance is 
increasingly reported worldwide. 
Carbapenemases are represented by 
3 molecular classes of β-lactamase: 
A, B, and D (1). The best known 
class A carbapenemase is Klebsiella 
pneumoniae carbapenemase (KPC); 
KPC-producing enterobacteria are re-
sponsible for many hospital outbreaks. 
Class B carbapenemases are metallo-
β-lactamases (MBL), which have the 
widest substrate spectrum. Class D 
OXA-type carbapenemases are found 
mainly in nonfermenting bacteria, 
except for OXA-48, which has been 
found only in enterobacteria.
In Hong Kong Special Adminis-
trative Region, People’s Republic of 
China, the Public Health Laboratory 
Centre routinely provides microbio-
logical diagnostic services for govern-
ment outpatient clinics and conﬁ  rms 
the identity of bacterial isolates re-
ferred by other clinical laboratories. 
In 2009, among 18 enterobacteria 
isolates determined to be not suscep-
tible to carbapenem, only 4 isolates—
Citrobacter freundii,  Enterobacter 
cloacae,  Escherichia coli, and K. 
pneumoniae—were conﬁ  rmed to pro-
duce carbapenemase. The E. coli iso-
late was from a government outpatient 
clinic; the others were from a regional 
hospital laboratory (Table).
For all 4 isolates, the modiﬁ  ed 
Hodge test (2) demonstrated enzyme 
activity against ertapenem and mero-
penem. Previously described PCR and 
sequencing methods (1) identiﬁ  ed the 
MBL IMP-4 in the C. freundii and K. 
pneumoniae isolates; the C. freundii 
isolate also possessed extended-spec-
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Letters
Letters commenting on recent articles 
as well as letters reporting cases, 
outbreaks, or original research are 
welcome. Letters commenting on ar-
ticles should contain no more than 
300 words and 5 references; they are 
more likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words and 
10 references. They may have 1 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.